Evidence map›Paper›PMID 35710369›Full record

ArticleCardiovascular diabetology2022

Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry.

Andrea Salzano, Roberta D'Assante, Massimo Iacoviello, Vincenzo Triggiani, Giuseppe Rengo, Francesco Cacciatore, Ciro Maiello, Giuseppe Limongelli, Daniele Masarone, Angela Sciacqua and 21 more

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Insulin-Heart Axis: Bridging Physiology to Insulin Resistance.International journal of molecular sciences · 2024
    Review
  10. Association between subclinical right ventricular alterations and aerobic exercise capacity in type 2 diabetes.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 4 countries.

Andrea Salzano *IRCCS SYNLAB SDN, Diagnostic and Nuclear Research Institute, Naples, Italy.
Roberta D'Assante *Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Massimo IacovielloCardiology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122, Foggia, Italy.
Vincenzo TriggianiInterdisciplinary Department of Medicine-Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, University of Bari 'A Moro', Bari, Italy.
Giuseppe RengoDepartment of Translational Medical Sciences, Federico II University, Naples, Italy.
Francesco CacciatoreDepartment of Translational Medical Sciences, Federico II University, Naples, Italy.
Ciro MaielloHeart Transplantation Unit, Monaldi Hospital, Azienda Ospedaliera Dei Colli, Naples, Italy.
Giuseppe LimongelliDivision of Cardiology, Monaldi Hospital, Azienda Ospedaliera Dei Colli, University of Campania Luigi Vanvitelli, Caserta, Italy.
Daniele MasaroneDivision of Cardiology, Monaldi Hospital, Azienda Ospedaliera Dei Colli, University of Campania Luigi Vanvitelli, Caserta, Italy.
Angela SciacquaDepartment of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy.
Pasquale Perrone FilardiDepartment of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Antonio ManciniOperative Unit of Endocrinology, Catholic University of the Sacred Heart, Rome, Italy.
Maurizio VolterraniDepartment of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy.
Olga VrizHeart Center Department, King Faisal Hospital & Research Center, Riyadh, Kingdom of Saudi Arabia.
Roberto CastelloDivision of General Medicine, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Andrea PassantinoScientific Clinical Institutes Maugeri, IRCCS, Pavia, Italy.
Michela CampoUnit of Endocrinology and Metabolic Diseases, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Pietro A ModestiDipartimento Di Medicina Sperimentale E Clinica, Università Degli Studi Di Firenze, Florence, Italy.
Alfredo De GiorgiDepartment of Medical Sciences, School of Medicine, Pharmacy and Prevention, University of Ferrara, Ferrara, Italy.
Michele ArcopintoDepartment of Translational Medical Sciences, Federico II University, Naples, Italy.
Paola GargiuloDepartment of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Maria PerticoneDepartment of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy.
Annamaria ColaoClinical Medicine and Surgery Department, Federico II University, Naples, Italy.
Salvatore MilanoDepartment of Laboratory Medicine, AOUP P. Giaccone, Palermo, Italy.
Agnese GaravagliaMedical Department, Novartis Farma S.P.A., Origgio, Italy.
Raffaele NapoliDepartment of Translational Medical Sciences, Federico II University, Naples, Italy.
Toru SuzukiDepartment of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, Glenfield Hospital, University of Leicester, Leicester, UK.
Eduardo Bossone *Italian Clinical Outcome Research and Reporting Program (I-CORRP), Naples, Italy.
Alberto M Marra *Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Antonio Cittadini *Department of Translational Medical Sciences, Federico II University, Naples, Italy. antonio.cittadini@unina.it.
T.O.S.CA. Investigators
Heidelberg University · DEFederico II University Hospital · ITNovartis (Italy) · ITUniversity of Ferrara · ITUniversity of Foggia · ITMagna Graecia University · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Florence · ITUniversity of Leicester · GBAzienda Ospedaliera Universitaria Integrata Verona · ITUniversità Cattolica del Sacro Cuore · ITAzienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITIRCCS Ospedale San Raffaele · ITIstituti Clinici Scientifici Maugeri · ITKing Faisal Specialist Hospital & Research Centre · SAOspedale Monaldi · ITSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Bari Aldo Moro · ITCenter for Outcomes Research and Clinical Epidemiology · ITClinica Mediterranea · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFindings from the T.O.S.CA. Registry recently reported that patients with concomitant chronic heart failure (CHF) and impairment of insulin axis (either insulin resistance-IR or diabetes mellitus-T2D) display increased morbidity and mortality. However, little information is available on the relative impact of IR and T2D on cardiac structure and function, cardiopulmonary performance, and their longitudinal changes in CHF.

methodsPatients enrolled in the T.O.S.CA. Registry performed echocardiography and cardiopulmonary exercise test at baseline and at a patient-average follow-up of 36 months. Patients were divided into three groups based on the degree of insulin impairment: euglycemic without IR (EU), euglycemic with IR (IR), and T2D.

resultsCompared with EU and IR, T2D was associated with increased filling pressures (E/e'ratio: 15.9 ± 8.9, 12.0 ± 6.5, and 14.5 ± 8.1 respectively, p < 0.01) and worse right ventricular(RV)-arterial uncoupling (RVAUC) (TAPSE/PASP ratio 0.52 ± 0.2, 0.6 ± 0.3, and 0.6 ± 0.3 in T2D, EU and IR, respectively, p < 0.05). Likewise, impairment in peak oxygen consumption (peak VO

conclusionThe higher risk of death and CV hospitalizations exhibited by HF-T2D patients in the T.O.S.CA. Registry is associated with progressive RV ventricular dysfunction and exercise impairment when compared to euglycemic CHF patients, supporting the pivotal importance of hyperglycaemia and right chambers in HF prognosis. Trial registration ClinicalTrials.gov identifier: NCT023358017.

Indexed as

Diabetes Mellitus, Type 2Heart FailureInsulinsVentricular Dysfunction, RightExercise TestHumansRegistriesStroke VolumeVentricular Function, RightInsulinsCardiopulmonary exercise testChronic heart failureDiabetesInsulin resistanceRight ventricleTOSCA

Identifiers

PMID35710369
PMCPMC9204878
OpenAlexW4282958738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.